Montelukast Starting Dose for Asthma or Allergic Rhinitis
Montelukast (Singulair) dosing for asthma and allergic rhinitis is 10 mg by mouth once daily (OD) in the evening for adults and adolescents aged ≥15 years. [1],[2] A 20 mg once-daily starting dose is not a labeled dosing regimen for asthma or allergic rhinitis. [1],[2]
Labeled Dose for Adults and Adolescents (≥15 Years)
- Asthma: 10 mg OD in the evening. [1],[2]
- Allergic rhinitis: 10 mg OD (dose timing may be morning or evening for allergic rhinitis efficacy). [1],[2]
- Patients with both asthma and allergic rhinitis: only one montelukast dose daily in the evening should be taken. [1],[2]
Medication Selection Algorithm
- Montelukast is indicated for asthma or allergic rhinitis when guideline-based alternatives are inadequate or not tolerated. [3]
- Intranasal corticosteroids and oral antihistamines are typical first-line options for allergic rhinitis in most patients; montelukast is reserved based on risk–benefit considerations. [3]
Initiation Thresholds and When to Avoid Up-Dosing
- Montelukast should be initiated at the labeled age-appropriate daily dose. [1],[2]
- Additional montelukast doses should not be added in patients already taking montelukast daily, including to prevent exercise-induced bronchoconstriction. [1],[2]
Key Safety Considerations for Dose Decisions
- Montelukast contains an FDA boxed warning for serious mental health side effects, and use for allergic rhinitis is restricted to patients not effectively treated with or unable to tolerate other allergy medicines. [3]
- Dose changes should not be made above labeled dosing without prescriber direction because montelukast is prescribed and studied at labeled doses for these indications. [1],[2],[3]
Common Pitfalls to Avoid
- Using a non-labeled higher dose (such as 20 mg OD) for asthma or allergic rhinitis. [1],[2]
- Doubling montelukast by taking more than one daily dose when already on montelukast for another indication. [1],[2]
Target Goals of Therapy
- The goal is symptom control of asthma or allergic rhinitis using the labeled montelukast dose regimen. [1],[2]
- Lack of control should prompt reassessment of the overall asthma or allergic rhinitis regimen rather than montelukast dose escalation. [3]